$DCTH Recent News Delcath cuts work force by 20% 7:07

New Post Public Reply Private Reply Replies (0) Message Board

Dec 30, 2013 at 10:45 AM

$DCTH Recent News

Delcath cuts work force by 20% 7:07 a.m. June 26, 2013 - MarketWatch.com
Friday’s movers: Regeneron, LinkedIn 3:18 p.m. May 3, 2013 - Wallace Witkowski
Delcath Systems falls 11% in premarket 7:22 a.m. Oct. 15, 2012 - Steve Gelsi
Hot stocks to watch 6:39 a.m. Sept. 4, 2012 - MarketWatch.com
Friday’s top gaining and declining stocks 3:33 p.m. May 25, 2012 - Val Brickates Kennedy
Delcath prices stock offering at 37% discount 11:06 a.m. May 25, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:10 p.m. Jan. 2, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:01 p.m. Jan. 2, 2012 - Kate Gibson
Stocks to watch Tuesday: Boeing, Verizon 12:58 p.m. Dec. 31, 2011 - MarketWatch
TI, Cisco edge up, MoSys slips after-hours 4:33 p.m. Dec. 30, 2011 - Benjamin Pimentel
Delcath reports inconclusive results from trial 11:02 a.m. Sept. 1, 2011 - MarketWatch.com
Friday’s biggest gaining and declining stocks 2:49 p.m. July 15, 2011 - Kate Gibson
Tuesday’s biggest gainers and decliners 4:57 p.m. Feb. 22, 2011 - Kate Gibson
Delcath, Clinical Data lead drug stocks south 3:36 p.m. Feb. 22, 2011 - Val Brickates Kennedy
Delcath implodes on FDA setback 9:57 a.m. Feb. 22, 2011 - Val Brickates Kennedy
In focus: Have the bears arrived? 7:30 p.m. Nov. 10, 2010 - Lawrence G. McMillan
S&P 500 pulls in from the 1,200 resistance 9:46 a.m. Oct. 27, 2010 - Michael Ashbaugh
Market bulls absorb weak Sept. jobs report 9:19 a.m. Oct. 8, 2010 - Michael Ashbaugh
Monday's biggest gaining and declining stocks 3:56 p.m. June 7, 2010 - MarketWatch
Thursday's biggest gaining and declining stocks 4:02 p.m. April 22, 2010 - MarketWatch

Delcath files for reverse split authorization, shares drop 2:19 p.m. Dec. 13, 2013 - Seeking Alpha
Delcath Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 5:35 a.m. Dec. 13, 2013 - benzinga.com
Delcath Systems' CEO Discusses Q3 2013 Results - Earnings Call Transcript 9:56 p.m. Nov. 6, 2013 - Seeking Alpha
10-Q: DELCATH SYSTEMS, INC. 4:49 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Delcath Systems, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 6, 2013 - Seeking Alpha
US Stock Futures Up Ahead Of Fed Speakers 5:24 a.m. Oct. 4, 2013 - benzinga.com
Delcath Systems Eliminates 33% of Workforce 4:33 a.m. Oct. 4, 2013 - benzinga.com
Hologic Scores Well in Brachtherapy Trial - Analyst Blog 4:40 p.m. Oct. 3, 2013 - Zacks.com
MAKO Buys Partner, Shares Hit 52-Week High - Analyst Blog 1:50 p.m. Oct. 3, 2013 - Zacks.com
Varian Unveils New Oncology Software - Analyst Blog 6:23 p.m. Sept. 25, 2013 - Zacks.com
Intuitive Surgical's Firefly Gets FDA Approval - Analyst Blog 2:30 p.m. Sept. 24, 2013 - Zacks.com
ARAY Platform Gains Foothold - Analyst Blog 3:35 p.m. Sept. 23, 2013 - Zacks.com
Radiosurgery Suite Boosts Varian Medical - Analyst Blog 2:20 p.m. Sept. 23, 2013 - Zacks.com
Thoratec Upped to Neutral - Analyst Blog 2:30 p.m. Sept. 20, 2013 - Zacks.com
PerkinElmer Upgraded to Neutral - Analyst Blog 1:40 p.m. Sept. 19, 2013 - Zacks.com
Moody's Changes Outlook of Fresenius - Analyst Blog 1:50 p.m. Sept. 18, 2013 - Zacks.com
Rochester General Gets MASI's Patient SafetyNet - Analyst Blog 1:50 p.m. Sept. 16, 2013 - Zacks.com
Delcath Board Implements Leadership Transition Plan 4:16 a.m. Sept. 13, 2013 - benzinga.com
Delcath Receives CRL from FDA for Melbleztm Kit NDA 4:15 a.m. Sept. 13, 2013 - benzinga.com
Delcath Systems Management Discusses Q2 2013 Results - Earnings Call Transcript 6:50 p.m. Aug. 6, 2013 - Seeking Alpha

DELCATH ANNOUNCES EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE RULE 6:31 a.m. Dec. 13, 2013 - Thomson Reuters ONE
Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc. 10:19 a.m. Dec. 11, 2013 - PR Newswire
Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Delcath Reports 2013 Third Quarter Results 4:05 p.m. Nov. 6, 2013 - PR Newswire
Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc. 10:34 a.m. Oct. 25, 2013 - PR Newswire
DELCATH TO RAISE APPROXIMATELY $7.5 MILLION 7:47 a.m. Oct. 23, 2013 - Thomson Reuters ONE
DELCATH TO REPORT THIRD QUARTER 2013 RESULTS ON NOVEMBER 6, 2013 9:46 a.m. Oct. 11, 2013 - Thomson Reuters ONE
Changes in Senior Management, Grants of Orphan Drug Designations, and Updates on Pipeline Development and NDA - Research Report on Vivus, Omeros, Delcath Systems, Achillion, and Zogenix 7:00 a.m. Oct. 7, 2013 - PR Newswire
DELCATH SYSTEMS ANNOUNCES STRATEGIC REORGANZATION 5:31 a.m. Oct. 4, 2013 - Thomson Reuters ONE
U.S. FDA GRANTS ORPHAN DRUG DESIGNATION TO DELCATH SYSTEMS FOR USE OF MELPHALAN HYDROCHLORIDE IN HCC 3:22 p.m. Oct. 1, 2013 - Thomson Reuters ONE
Today's Research: Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn Inc. 7:09 a.m. Sept. 30, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on DCTH, GALE, MKTO and NSPH 7:40 a.m. Sept. 16, 2013 - ACCESSWIRE
DELCATH SYSTEMS BOARD OF DIRECTORS IMPLEMENTS LEADERSHIP TRANSITION PLAN 5:06 a.m. Sept. 13, 2013 - Thomson Reuters ONE
DELCATH RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR MELBLEZTM KIT NEW DRUG APPLICATION 5:01 a.m. Sept. 13, 2013 - Thomson Reuters ONE
Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc. 11:38 a.m. Aug. 21, 2013 - PR Newswire
DELCATH TO PRESENT AT WEDBUSH LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE ON AUGUST 13, 2013 3:03 p.m. Aug. 7, 2013 - Thomson Reuters ONE
DELCATH REPORTS 2013 SECOND QUARTER RESULTS 3:21 p.m. Aug. 6, 2013 - Thomson Reuters ONE
Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma 8:00 a.m. July 23, 2013 - PR Newswire
DELCATH TO REPORT SECOND QUARTER 2013 RESULTS ON AUGUST 6, 2013 5:31 a.m. July 22, 2013 - Thomson Reuters ONE
Today's Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn 7:00 a.m. July 18, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CelluPro Earns Global Recognition with EXCiPACT Certification

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

CalExitNow Fights Federal Interference in CA Elections

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Papa John's Faces Investor Lawsuit: Class Action Looms

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

BYD's Chip Mastery Amid China's Auto Supply Tensions

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

ACG Moves to Acquire Ke?kek for $7.85M Gold Venture

Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....

Beazer Homes Sale Scrutinized for Shareholder Impact

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

Europe's Largest Carbon Capture Facility Launches

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

York Space Systems Faces Investor Lawsuit Over Claims

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...